Literature DB >> 25682601

Global transcriptome and chromatin occupancy analysis reveal the short isoform of GATA1 is deficient for erythroid specification and gene expression.

Timothy M Chlon1, Maureen McNulty2, Benjamin Goldenson2, Alexander Rosinski2, John D Crispino3.   

Abstract

GATA1 is a master transcriptional regulator of the differentiation of several related myeloid blood cell types, including erythrocytes and megakaryocytes. Germ-line mutations that cause loss of full length GATA1, but allow for expression of the short isoform (GATA1s), are associated with defective erythropoiesis in a subset of patients with Diamond Blackfan Anemia. Despite extensive studies of GATA1s in megakaryopoiesis, the mechanism by which GATA1s fails to support normal erythropoiesis is not understood. In this study, we used global gene expression and chromatin occupancy analysis to compare the transcriptional activity of GATA1s to GATA1. We discovered that compared to GATA1, GATA1s is less able to activate the erythroid gene expression program and terminal differentiation in cells with dual erythroid-megakaryocytic differentiation potential. Moreover, we found that GATA1s bound to many of its erythroid-specific target genes less efficiently than full length GATA1. These results suggest that the impaired ability of GATA1s to promote erythropoiesis in DBA may be caused by failure to occupy erythroid-specific gene regulatory elements. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25682601      PMCID: PMC4420206          DOI: 10.3324/haematol.2014.112714

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  50 in total

1.  SCL and associated proteins distinguish active from repressive GATA transcription factor complexes.

Authors:  Tamara Tripic; Wulan Deng; Yong Cheng; Ying Zhang; Christopher R Vakoc; Gregory D Gregory; Ross C Hardison; Gerd A Blobel
Journal:  Blood       Date:  2008-11-14       Impact factor: 22.113

2.  Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis.

Authors:  Jan-Henning Klusmann; Frank J Godinho; Kirsten Heitmann; Aliaksandra Maroz; Mia Lee Koch; Dirk Reinhardt; Stuart H Orkin; Zhe Li
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

3.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities.

Authors:  Sven Heinz; Christopher Benner; Nathanael Spann; Eric Bertolino; Yin C Lin; Peter Laslo; Jason X Cheng; Cornelis Murre; Harinder Singh; Christopher K Glass
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

4.  Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression.

Authors:  Yong Cheng; Weisheng Wu; Swathi Ashok Kumar; Duonan Yu; Wulan Deng; Tamara Tripic; David C King; Kuan-Bei Chen; Ying Zhang; Daniela Drautz; Belinda Giardine; Stephan C Schuster; Webb Miller; Francesca Chiaromonte; Yu Zhang; Gerd A Blobel; Mitchell J Weiss; Ross C Hardison
Journal:  Genome Res       Date:  2009-11-03       Impact factor: 9.043

5.  STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice.

Authors:  Zan Huang; Terri D Richmond; Andrew G Muntean; Dwayne L Barber; Mitchell J Weiss; John D Crispino
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  Genome-wide mapping of in vivo protein-DNA interactions.

Authors:  David S Johnson; Ali Mortazavi; Richard M Myers; Barbara Wold
Journal:  Science       Date:  2007-05-31       Impact factor: 47.728

7.  MEME SUITE: tools for motif discovery and searching.

Authors:  Timothy L Bailey; Mikael Boden; Fabian A Buske; Martin Frith; Charles E Grant; Luca Clementi; Jingyuan Ren; Wilfred W Li; William S Noble
Journal:  Nucleic Acids Res       Date:  2009-05-20       Impact factor: 16.971

8.  Sole-Search: an integrated analysis program for peak detection and functional annotation using ChIP-seq data.

Authors:  Kimberly R Blahnik; Lei Dou; Henriette O'Geen; Timothy McPhillips; Xiaoqin Xu; Alina R Cao; Sushma Iyengar; Charles M Nicolet; Bertram Ludäscher; Ian Korf; Peggy J Farnham
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971

9.  Direct binding of pRb/E2F-2 to GATA-1 regulates maturation and terminal cell division during erythropoiesis.

Authors:  Zahra Kadri; Ritsuko Shimizu; Osamu Ohneda; Leila Maouche-Chretien; Sylvie Gisselbrecht; Masayuki Yamamoto; Paul-Henri Romeo; Philippe Leboulch; Stany Chretien
Journal:  PLoS Biol       Date:  2009-06-09       Impact factor: 8.029

10.  Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data.

Authors:  Anton Valouev; David S Johnson; Andreas Sundquist; Catherine Medina; Elizabeth Anton; Serafim Batzoglou; Richard M Myers; Arend Sidow
Journal:  Nat Methods       Date:  2008-09       Impact factor: 28.547

View more
  20 in total

Review 1.  GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.

Authors:  Te Ling; John D Crispino; Maria Zingariello; Fabrizio Martelli; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2018-02-19       Impact factor: 2.929

2.  Molecular convergence in ex vivo models of Diamond-Blackfan anemia.

Authors:  Kelly A O'Brien; Jason E Farrar; Adrianna Vlachos; Stacie M Anderson; Crystiana A Tsujiura; Jens Lichtenberg; Lionel Blanc; Eva Atsidaftos; Abdel Elkahloun; Xiuli An; Steven R Ellis; Jeffrey M Lipton; David M Bodine
Journal:  Blood       Date:  2017-04-04       Impact factor: 22.113

3.  GATA1 erythroid-specific regulation of SEC23B expression and its implication in the pathogenesis of congenital dyserythropoietic anemia type II.

Authors:  Roberta Russo; Immacolata Andolfo; Antonella Gambale; Gianluca De Rosa; Francesco Manna; Alessandra Arillo; Farooq Wandroo; Maria Grazia Bisconte; Achille Iolascon
Journal:  Haematologica       Date:  2017-05-26       Impact factor: 9.941

Review 4.  Cohesin Mutations in Myeloid Malignancies.

Authors:  Joseph B Fisher; Maureen McNulty; Michael J Burke; John D Crispino; Sridhar Rao
Journal:  Trends Cancer       Date:  2017-04

5.  Unexpected role for p19INK4d in posttranscriptional regulation of GATA1 and modulation of human terminal erythropoiesis.

Authors:  Xu Han; Jieying Zhang; Yuanliang Peng; Minyuan Peng; Xiao Chen; Huiyong Chen; Jianhui Song; Xiao Hu; Mao Ye; Jianglin Li; Vijay G Sankaran; Christopher D Hillyer; Narla Mohandas; Xiuli An; Jing Liu
Journal:  Blood       Date:  2016-11-22       Impact factor: 22.113

6.  A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5'UTR GATA1s Splice Mutation.

Authors:  Jacob Zucker; Constance Temm; Magdalena Czader; Grzegorz Nalepa
Journal:  Pediatr Blood Cancer       Date:  2015-12-29       Impact factor: 3.167

7.  The DEK Oncoprotein Is a Critical Component of the EKLF/KLF1 Enhancer in Erythroid Cells.

Authors:  Felix Lohmann; Mohan Dangeti; Shefali Soni; Xiaoyong Chen; Antanas Planutis; Margaret H Baron; Kyunghee Choi; James J Bieker
Journal:  Mol Cell Biol       Date:  2015-08-24       Impact factor: 4.272

Review 8.  GATA1 mutations in red cell disorders.

Authors:  Te Ling; John D Crispino
Journal:  IUBMB Life       Date:  2019-10-25       Impact factor: 3.885

9.  Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3.

Authors:  Motoki Takaku; Sara A Grimm; Bony De Kumar; Brian D Bennett; Paul A Wade
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

10.  Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesis.

Authors:  Te Ling; Yehudit Birger; Monika J Stankiewicz; Nissim Ben-Haim; Tomer Kalisky; Avigail Rein; Eitan Kugler; Wei Chen; Chunling Fu; Kevin Zhang; Hiral Patel; Jacek W Sikora; Young Ah Goo; Neil Kelleher; Lihua Zou; Shai Izraeli; John D Crispino
Journal:  Blood       Date:  2019-11-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.